yahoo finance

AT&T Surprises With 3Q Sales Win; Shares Gain 5%

AT&T reported better-than-feared quarterly sales driven by “solid” wireless and fiber broadband subscriber growth, sending shares up more than 5% in morning trading. …

American Airlines Posts $2.4B Quarterly Loss; Street Sees 22% Downside

American Airlines posted a $2.4 billion quarterly loss as the pandemic-induced travel halt put a dent on its peak summer season.

STMicroelectronics To Top 2020 Sales Guidance After Quarterly Blowout

STMicroelectronics outperformed quarterly sales expectations driven by a rise in demand for microcontrollers and automotive products and “significantly” better-than-expected market conditions. Shares are …

Sun Life Financial To Snap Up 51% Stake In Crescent For $338M

Sun Life Financial plans to buy a 51% majority stake in alternative credit investment manager Crescent Capital for up to $338 million. Canadian …

Brightcove Pops 12% After Record Sales Quarter; Street Says Buy

Shares in Brightcove popped more than 12% after the online video company reported third-quarter results that outperformed Wall Street estimates as businesses are …

BD’s Covid-19-Flu Combo Test Wins European Clearance

Becton, Dickinson and Co. announced on Wednesday that its diagnostic test kit for both flu and Covid-19 detection has been cleared by European …

Telia Inks 5G Network Deals With Ericsson, Nokia

Telia has inked multi-year deals with Nokia and Ericsson to upgrade the telecom operator’s 4G networks to 5G. Stockholm-based Telia (TLSNF) said that …

Iberdrola’s Avangrid In $8.3B Renewable Energy Merger With PNM

Shares in PNM Resources are surging almost 8% in Wednesday’s pre-market trading after the company agreed to a $8.3 billion merger deal with …

Xeris Wins FDA Fast Track Path For Epilepsy Treatment; Shares Spike 9%

Shares in Xeris Pharmaceuticals are rising 9% in Wednesday’s pre-market session after the company announced that the US Food and Drug Administration (FDA) …

AstraZeneca’s Covid-19 Trial Slated To Resume This Week – Report

AstraZeneca’s US Covid-19 vaccine trial is poised to resume as early as this week after the US Food and Drug Administration completed its …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts